Latest filing published 10 Sept 2026 for Grace Therapeutics, Inc., €133k.
All filings by Prashant Kohli on record concern Grace Therapeutics, Inc. Between 28 August 2026 and 9 September 2026, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (2 purchases, €283k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise.
Most recently, on 10 September 2026, the filings show an open-market purchase worth €133k in Grace Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations